Latest news
Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study - TradingViewTradingView · Mon, 10 Aug 2026 18:06:36 GMTAquestive Therapeutics shares jump after encouraging Anaphylm study results - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 14:24:58 GMTAquestive Advances Anaphylm With Positive Study Results - TipRanksTipRanks · Mon, 10 Aug 2026 11:35:29 GMTAquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:47 GMTAquestive Reports Positive Human Factors and PK Results for Anaphylm, Plans NDA Resubmission Q3 2026 - TradingViewTradingView · Mon, 10 Aug 2026 11:13:01 GMTAquestive Therapeutics Q1 2026 Earnings: EPS Beat Drives Positive Sentiment - Revenue Inflection Point - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMTAquestive Therapeutics Q1 2026 Earnings: EPS Beat Drives Positive Sentiment - Profitability Analysis - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 07:00:00 GMT